Ghost Tree Capital, LLC
- SEC CIK
- 0001595851
- Latest filing
- Nov 14, 2024
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 16, 2022. Long positions only; changes compare share counts with Q3 2021.
- Positions
- 43
- −12 vs. Q3 2021
- Portfolio value
- $261.1M
- −$42.2M (−13.9%) vs. Q3 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ASNDAscendis Pharma A/S | SPONSORED ADR | 190,000 | $25.6M | 9.8% | +70,000+58.3% | Added | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 325,000 | $15.4M | 5.9% | +125,000+62.5% | Added | History |
| COGTCogent Biosciences, Inc. | COM | 1,700,000 | $14.6M | 5.6% | +200,000+13.3% | Added | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 350,000 | $13.5M | 5.2% | +95,000+37.3% | Added | History |
| RAPTRAPT Therapeutics, Inc. | COM | 350,000 | $12.9M | 4.9% | +100,000+40.0% | Added | History |
| MRUSMerus N.V. | COM | 350,000 | $11.1M | 4.3% | +275,000+366.7% | Added | History |
| ISEEIVERIC bio, Inc. | COM | 625,000 | $10.4M | 4.0% | −100,000−13.8% | Reduced | History |
| VRDNViridian Therapeutics, Inc. | COM | 500,000 | $9.88M | 3.8% | +150,000+42.9% | Added | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 425,000 | $9.28M | 3.6% | +75,000+21.4% | Added | History |
| ARVNArvinas, Inc. | COM | 110,000 | $9.04M | 3.5% | −40,000−26.7% | Reduced | History |
| SRPTSarepta Therapeutics, Inc. | COM | 100,000 | $9.01M | 3.4% | +100,000 | New | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 80,000 | $6.72M | 2.6% | +15,000+23.1% | Added | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 300,000 | $6.57M | 2.5% | −275,000−47.8% | Reduced | History |
| PCVXVaxcyte, Inc. | COM | 250,000 | $5.95M | 2.3% | +90,000+56.3% | Added | History |
| FOLDAmicus Therapeutics, Inc. | COM | 500,000 | $5.78M | 2.2% | +235,000+88.7% | Added | History |
| SRRASierra Oncology, Inc. | COM NEW | 250,000 | $5.43M | 2.1% | +50,000+25.0% | Added | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 30,000 | $5.09M | 1.9% | +30,000 | New | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 750,000 | $5.04M | 1.9% | 00.0% | Unchanged | History |
| WHWKWhitehawk Therapeutics, Inc. | COM | 200,000 | $4.83M | 1.8% | +200,000 | New | History |
| ACRSAclaris Therapeutics, Inc. | COM | 325,000 | $4.73M | 1.8% | +50,000+18.2% | Added | History |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 210,000 | $4.64M | 1.8% | +110,000+110.0% | Added | History |
| RLMDRelmada Therapeutics, Inc. | COM | 200,000 | $4.51M | 1.7% | 00.0% | Unchanged | History |
| MRTXMirati Therapeutics, Inc. | COM | 30,000 | $4.40M | 1.7% | −30,000−50.0% | Reduced | History |
| CYPHCypherpunk Technologies Inc. | COM | 1,350,000 | $4.37M | 1.7% | −300,000−18.2% | Reduced | History |
| KZRKezar Life Sciences, Inc. | COM | 250,000 | $4.18M | 1.6% | +250,000 | New | History |
| STSASatsuma Pharmaceuticals, Inc. | COM | 904,225 | $4.07M | 1.6% | 00.0% | Unchanged | History |
| VTGNVistagen Therapeutics, Inc. | COM NEW | 2,000,000 | $3.90M | 1.5% | 00.0% | Unchanged | History |
| TARSTarsus Pharmaceuticals, Inc. | COM | 170,000 | $3.83M | 1.5% | 00.0% | Unchanged | History |
| Bellus Health Inc New07987C204 | COM NEW | 450,000 | $3.62M | 1.4% | +50,000+12.5% | Added | – |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 118,344 | $3.36M | 1.3% | −31,656−21.1% | Reduced | History |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 295,000 | $3.24M | 1.2% | +295,000 | New | History |
| NMTR9 Meters Biopharma, Inc. | COM | 3,250,000 | $3.18M | 1.2% | +500,000+18.2% | Added | History |
| KURAKura Oncology, Inc. | COM | 225,000 | $3.15M | 1.2% | −200,000−47.1% | Reduced | History |
| XENEXenon Pharmaceuticals Inc. | COM | 100,000 | $3.12M | 1.2% | −690,000−87.3% | Reduced | History |
| CTICCti Biopharma Corp | COM | 1,200,000 | $2.98M | 1.1% | −400,000−25.0% | Reduced | History |
| DSGNDesign Therapeutics, Inc. | COM | 135,000 | $2.89M | 1.1% | +135,000 | New | History |
| LRMRLarimar Therapeutics, Inc. | COM | 225,000 | $2.43M | 0.9% | +25,000+12.5% | Added | History |
| GHRSGH Research PLC | ORDINARY SHARES | 100,000 | $2.33M | 0.9% | −300,000−75.0% | Reduced | History |
| GBTGlobal Blood Therapeutics, Inc. | COM | 60,000 | $1.76M | 0.7% | +60,000 | New | History |
| IMUXImmunic, Inc. | COM | 165,000 | $1.58M | 0.6% | −100,000−37.7% | Reduced | History |
| RETAReata Pharmaceuticals Inc | CL A | 55,000 | $1.45M | 0.6% | +55,000 | New | History |
| PRDSPardes Biosciences, Inc. | COM | 50,000 | $819.0K | 0.3% | +50,000 | New | History |
| CABACabaletta Bio, Inc. | COM | 135,000 | $512.0K | 0.2% | +35,000+35.0% | Added | History |
Options (3)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
Sold out since Q3 2021 (21)
Positions held at the end of Q3 2021 that are gone from this filing.
| Security | Class | Shares in Q3 2021 | Value in Q3 2021 | % of portfolio in Q3 2021 | History |
|---|---|---|---|---|---|
| IOVAIovance Biotherapeutics, Inc. | COM | 700,000 | $17.3M | 5.7% | History |
| ALLKAllakos Inc. | COM | 85,000 | $9.00M | 3.0% | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 700,000 | $6.15M | 2.0% | History |
| AVIRAtea Pharmaceuticals, Inc. | COM | 150,000 | $5.26M | 1.7% | History |
| MLTXMoonLake Immunotherapeutics | COM CL A | 500,000 | $4.94M | 1.6% | History |
| PRAXPraxis Precision Medicines, Inc. | COM | 250,000 | $4.62M | 1.5% | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 100,000 | $4.16M | 1.4% | History |
| GYREGyre Therapeutics, Inc. | COM NEW | 1,000,000 | $4.11M | 1.4% | History |
| TCRRTCR2 Therapeutics Inc. | COM | 477,323 | $4.06M | 1.3% | History |
| ALLOAllogene Therapeutics, Inc. | COM | 150,000 | $3.85M | 1.3% | History |
| FATEFate Therapeutics Inc | COM | 50,000 | $2.96M | 1.0% | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 75,000 | $2.88M | 0.9% | History |
| MRNAModerna, Inc. | Stock | 5,300 | $2.04M | 0.7% | History |
| ALECAlector, Inc. | COM | 80,000 | $1.83M | 0.6% | History |
| FULCFulcrum Therapeutics, Inc. | COM | 50,000 | $1.41M | 0.5% | History |
| CMRXChimerix Inc | COM | 200,000 | $1.24M | 0.4% | History |
| OTICOtonomy, Inc. | COM | 450,000 | $864.0K | 0.3% | History |
| CASICASI Pharmaceuticals, Inc (DE) | COM | 650,000 | $774.0K | 0.3% | History |
| BNTXBioNTech SE | SPONSORED ADS | 2,000 | $546.0K | 0.2% | History |
| TBIOTelesis Bio Inc. | COM | 35,000 | $390.0K | 0.1% | History |
| PRVBProvention Bio, Inc. | COM | 50,000 | $320.0K | 0.1% | History |